<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01833650</url>
  </required_header>
  <id_info>
    <org_study_id>AC-HCS-89</org_study_id>
    <nct_id>NCT01833650</nct_id>
  </id_info>
  <brief_title>The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer</brief_title>
  <official_title>A Randomized Controlled Trial of the Effectiveness of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cyprus University of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bank of Cyprus Oncology Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cyprus University of Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of honey mouthwashes in the
      prevention of salivary side effects of 131I (radioiodine) therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grade of sialadenitis</measure>
    <time_frame>Change from Baseline grade of sialadenitis at 6 and 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Grade of Xerostomia</measure>
    <time_frame>Change from Baseline grade of xerostomia at 6 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Health related quality of life</measure>
    <time_frame>Change from Baseline level of health related quality of life at 6 and 24 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Salivary Quantity (Quantitative Salivary Scintigraphy)</measure>
    <time_frame>Change from Baseline quantity of saliva at 6 and 24 months</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Thyroid Cancer</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm represents the current standard care in patients with thyroid cancer undergoing radioiodine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Candy plus thymus honey mouthwash 12</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will consist 30 patients and will be the one of the intervention groups where each patient will be instructed to suck 1 or 2 lemon candies every 2-3 h in the daytime plus 4 thymus honey mouthwashes in between (at least one hour after the candy sucking) starting 12 hours after the ingestion of 131I therapy and for a duration of no more than 4 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Candy plus thymus honey mouthwash 24</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will consist 30 patients and will be the one of the intervention groups where each patient will be instructed to suck 1 or 2 lemon candies every 2-3 h in the daytime plus 4 thymus honey mouthwashes in between (at least one hour after the candy sucking) starting 24 hours after the ingestion of 131I therapy and for a duration of no more than 4 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Candy plus thymus honey mouthwash 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will consist 30 patients and will be the one of the intervention groups where each patient will be instructed to suck 1 or 2 lemon candies every 2-3 h in the daytime plus 4 thymus honey mouthwashes in between (at least one hour after the candy sucking) starting immediate after the ingestion of 131I therapy (about 1 hour) and for a duration of no more than 4 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>thymus honey mouthwash</intervention_name>
    <arm_group_label>Candy plus thymus honey mouthwash 12</arm_group_label>
    <arm_group_label>Candy plus thymus honey mouthwash 24</arm_group_label>
    <arm_group_label>Candy plus thymus honey mouthwash 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years old

          -  They had a histological diagnosis of papillary, follicular, medullary or anaplastic
             thyroid cancer

          -  They had undergone total thyroidectomy

          -  They were able to provide consent

        Exclusion Criteria:

          -  patients who had distant metastases,

          -  a history of salivary-gland disorders,

          -  collagen tissue disease

          -  diabetes mellitus,

          -  previous radioiodine therapy or external radiation to the head or neck

          -  allergy to the honey
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Charalambous, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cyprus University of Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Charalambous, PhD</last_name>
    <phone>+35725002011</phone>
    <email>andreas.charalambous@cut.ac.cy</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Savvas Frangos, MD</last_name>
    <phone>+35722841300</phone>
    <email>savvas.frangos@bococ.org.cy</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bank of Cyprus Oncology</name>
      <address>
        <city>Nicosia</city>
        <zip>2006</zip>
        <country>Cyprus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andri Christou, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Cyprus</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2013</study_first_submitted>
  <study_first_submitted_qc>April 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2013</study_first_posted>
  <last_update_submitted>January 15, 2018</last_update_submitted>
  <last_update_submitted_qc>January 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cyprus University of Technology</investigator_affiliation>
    <investigator_full_name>Dr. Andreas Charalambous</investigator_full_name>
    <investigator_title>Assistant Professor of Oncology and Palliative Care</investigator_title>
  </responsible_party>
  <keyword>thyroid cancer</keyword>
  <keyword>radioiodine treatment</keyword>
  <keyword>xerostomia</keyword>
  <keyword>sialadenitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

